Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo.
about
G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and preventionTherapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?Serelaxin: a novel therapy for acute heart failure with a range of hemodynamic and non-hemodynamic actionsSerelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.Relaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α)Portal hypertension as immune mediate disease.Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.Nitric oxide in liver diseases.Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.New cellular and molecular targets for the treatment of portal hypertension.Serelaxin in clinical development: past, present and future.Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism.Anti-fibrotic actions of relaxin.Angiocrine signaling in the hepatic sinusoids in health and disease.Molecular pathophysiology of portal hypertension.Novel Anti-fibrotic Therapies.Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.A single adenovirus-mediated relaxin delivery attenuates established liver fibrosis in rats.In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosisBiology of portal hypertension.Molecular imaging of fibrosis using a novel collagen-binding peptide labelled with 99mTc on SPECT/CT.The STAT3-IL-10-IL-6 Pathway Is a Novel Regulator of Macrophage Efferocytosis and Phenotypic Conversion in Sterile Liver Injury.Serelaxin Induces Notch1 Signaling and Alleviates Hepatocellular Damage in Orthotopic Liver Transplantation.Recombinant Relaxin Protects Liver Transplants from Ischemia Damage via Hepatocyte Glucocorticoid Receptor: From Bench-to-Bedside.
P2860
Q26744192-9A072CFF-4107-415B-A893-04DB6E2E183DQ26829662-E9FDD0B1-DC8D-41E0-9485-246BA06D8968Q33970136-3DD51D00-81DF-4B00-95C3-28612E1A6E65Q34726868-C2ACBE16-FBA9-4055-8C3D-0443B92FB2C2Q34958919-8D5D7C3F-D62E-40E8-B0FD-7135350BD53BQ35197361-FB592D15-3973-4AEE-9F22-88E35EA82F41Q35651447-3E1201FC-4C6F-4907-8316-F7C4AE74B016Q35940869-3CADB774-4304-4025-97C5-3C08402C88B4Q36292811-806DCE66-ADF6-4802-BA37-F487BE8D4842Q38383418-D7A2570E-ED75-4ED6-998B-7453040C3700Q38778886-B54DC01A-6FE6-4A88-913B-3E9BD234668BQ38782445-3048393D-24DA-4017-A5F7-0478C74CB192Q38850557-FB479FE8-AC45-40C2-858D-FB54766EC21BQ38861983-CB9D8C34-0281-41A0-8FCB-AB597C5BF9ABQ39148718-1CF919C4-AEFC-4642-8DE7-0C22AA1849F6Q39377055-E6CF454C-5A1B-47F7-BC02-F6BB81ABCD7DQ39678375-82FB41EE-D755-428D-9BE4-443E5EBAD571Q40832601-2DF68F45-2B1C-4971-9798-9DA390FC1A74Q41537671-B2475A64-02A4-4F6D-955B-C265B3D1BE31Q41926996-57987BFF-AF13-49DD-8F21-591304B8066AQ47874043-EE68F83C-47FF-418D-886D-3AB393CD8FB6Q48352308-C1EB6936-DA87-4920-8E0E-223AFE217F87Q48374317-D585D11E-EA10-4569-BACE-53C31266FE1AQ49718692-4945AB4F-C00B-4B70-B691-13143E7D65B1Q49922719-3950F447-9FE5-4B3F-A18A-695AD32F5570
P2860
Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Relaxin modulates human and ra ...... s portal hypertension in vivo.
@en
Relaxin modulates human and ra ...... s portal hypertension in vivo.
@nl
type
label
Relaxin modulates human and ra ...... s portal hypertension in vivo.
@en
Relaxin modulates human and ra ...... s portal hypertension in vivo.
@nl
prefLabel
Relaxin modulates human and ra ...... s portal hypertension in vivo.
@en
Relaxin modulates human and ra ...... s portal hypertension in vivo.
@nl
P2093
P50
P356
P1433
P1476
Relaxin modulates human and ra ...... s portal hypertension in vivo.
@en
P2093
Alexander Henke
Annette L Hayden
Antonella Pellicoro
Ben M Stutchfield
Joerg Schrader
John P Iredale
Jonathan A Fallowfield
Marc Princivalle
Palak J Trivedi
Rebecca L Aucott
P304
P356
10.1002/HEP.26627
P407
P577
2014-03-03T00:00:00Z